首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1634154

全球微生物培養市場 - 2025 - 2032

Global Microbiology Culture Market - 2025 - 2032

出版日期: 2025年01月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球微生物培養市場規模達74.3億美元，預計2032年將達到131.9億美元，2025-2032年預測期間複合年成長率為6.87%。

微生物培養透過在實驗室環境中增加預設的生活方式介質來繁殖微生物。微生物培養用於確定生物體的類型、所研究模式內該生物體的豐度或兩者。

微生物培養技術對於臨床診斷、工業應用和科學研究等不同領域的微生物（特別是細菌）的研究和鑑定至關重要。這些技術涉及使用各種促進生長、分離和表徵的培養基在受控環境中培養微生物。由於對精確診斷、新型抗生素開發和持續生物技術進步的需求不斷增加，全球微生物培養市場正在經歷顯著成長。

市場動態：

驅動程式和限制

生物製藥需求不斷成長

微生物培養市場的成長受到幾個關鍵因素的推動，其中主要驅動力之一是對生物製藥的需求不斷成長。微生物培養對於單株抗體、疫苗和重組蛋白等生物製藥的生產至關重要。這種需求的增加需要專門的微生物菌株和培養物，有助於市場擴張。

生物加工技術的創新，特別是發酵和細胞培養技術，在推動市場方面也發揮著至關重要的作用。這些過程需要高品質的微生物培養物來提高效率和產量，進一步促進了對先進微生物培養物的需求。

此外，人們越來越重視依賴微生物培養物的生物製劑的再生醫學，正在擴大這些培養物在治療應用中的範圍。隨著再生醫學的進步，對支持細胞療法和組織再生的特定微生物培養物的需求不斷增加。

隨著生物製藥行業的法規日益嚴格，對精確微生物測試和驗證的需求也不斷成長。這增加了在品質控制和保證方面對專門微生物培養的需求，以確保生物製藥產品的安全性和有效性。

此外，微生物培養系統的持續創新，特別是在生物製藥領域，正在推動市場向前發展。例如，2023年5月，HiMedia Laboratories與美國Advanced Instruments合作推出了Anoxomat III厭氧培養系統，這是一種旨在加強微生物學研究和培養管理的最先進系統。這些培養系統的創新有助於提高實驗室效率並簡化微生物檢測。

開發成本高

開發先進的微生物培養物，尤其是生物製藥和再生醫學等專業應用，需要在研究、設備和確保合規性方面進行大量投資。對於中小型企業（SME）來說，這些高成本可能是一個主要障礙。他們往往缺乏資金來投資這些專業產品所需的必要基礎設施或創新。這創造了一個環境，讓擁有更多資本的大公司主導市場，限制競爭並減少微生物培養供應商的多樣性。因此，中小企業可能難以創新或擴大生產規模，這可能會減緩整體市場成長並限制消費者可用的解決方案的範圍。

Microbiology culture techniques are essential for studying and identifying microorganisms, particularly bacteria, across diverse sectors, including clinical diagnostics, industrial applications, and scientific research. These techniques involve the cultivation of microorganisms in controlled environments using various culture media that promote growth, isolation, and characterization. The global market for microbiology cultures is experiencing significant growth, driven by an increased need for precise diagnostics, novel antibiotics development, and ongoing biotechnology advancements.

Market Dynamics: Drivers & Restraints

Rising demand for biopharmaceuticals

The growth of the microbiology culture market is fueled by several key factors, with one of the primary drivers being the rising demand for biopharmaceuticals. Microbial cultures are essential in the production of biopharmaceuticals, such as monoclonal antibodies, vaccines, and recombinant proteins. This increased demand necessitates specialized microbial strains and cultures, contributing to market expansion.

Innovations in bioprocessing technologies, particularly fermentation and cell culture techniques, also play a crucial role in driving the market. These processes require high-quality microbial cultures to improve efficiency and output, further promoting the need for advanced microbiological cultures.

Additionally, the growing emphasis on regenerative medicine, which relies on biologics derived from microbial cultures, is expanding the scope of these cultures in therapeutic applications. As regenerative medicine advances, the demand for specific microbial cultures to support cell-based therapies and tissue regeneration is rising.

With increasingly stringent regulations in the biopharmaceutical industry, the demand for precise microbiological testing and validation is also growing. This has heightened the need for specialized microbial cultures in quality control and assurance, ensuring the safety and efficacy of biopharmaceutical products.

Furthermore, continuous innovations in microbiology culture systems, particularly in the biopharmaceutical sector, are driving the market forward. For example, in May 2023, HiMedia Laboratories partnered with US-based Advanced Instruments to launch the Anoxomat III Anaerobic Culture System, a state-of-the-art system designed to enhance microbiology research and culture management. These innovations in culture systems are helping improve laboratory efficiencies and streamline microbiological testing.

High development costs

Developing advanced microbial cultures, especially for specialized applications like biopharmaceuticals and regenerative medicine, involves significant investments in research, equipment, and ensuring regulatory compliance. For small and medium-sized enterprises (SMEs), these high costs can be a major barrier. They often lack the financial resources to invest in the necessary infrastructure or innovation required for these specialized products. This creates an environment where larger companies with more capital dominate the market, limiting competition and reducing the diversity of microbial culture suppliers. As a result, SMEs may struggle to innovate or scale up their production, which can slow overall market growth and limit the range of solutions available to consumers.

Segment Analysis

The global microbiology culture market is segmented based on product, culture media type, consistency, application, and region.

Product:

Food & beverage industry segment is expected to dominate the global microbiology culture share

Food & Beverage Industry segment is expected to dominate the microbiology culture market. As public awareness of food safety rises, producers are increasingly using microbiological testing to ensure that their products are safe. This demand creates a requirement for particular microbial cultures used in testing and quality assurance.

Culture media for food microbiology are crucial for ensuring food safety by detecting, isolating, and identifying microbes. Selective and differential culture media are critical in identifying potential pathogens and measuring microbial contamination levels, allowing for early intervention and prevention of foodborne diseases.

Microbiological cultures are essential for detecting contamination, ensuring product quality, and complying with strict food safety regulations imposed by authorities worldwide. With the growing demand for organic and minimally processed foods, the need for reliable microbiological testing to guarantee safety is also rising.

Furthermore, advancements in rapid detection technologies are making microbiological testing faster and more efficient, prompting food producers to adopt these methods to maintain safety standards and avoid costly product recalls. As a result, the food and beverage industry's commitment to maintaining high safety standards positions it as the dominant player in the microbiology culture market.

Geographical Analysis

North America is expected to hold a significant position in the global microbiology culture share.

This is due to the increasing testing with the increasing number of infections in the region. For instance, according to a report by the Centers for Disease Control and Prevention, it stated that Salmonella causes about 1.35 million illnesses, 26,500 hospitalizations, and 420 deaths in the United States every year.

Moreover, increased microbiological testing in the food and beverage industry has encouraged the expansion of the microbiology culture market in the United States.

The rising production of biopharmaceuticals is increasing the demand for microbiology cultures to study the antibiotic resistance of the particular organism against the drug and the increasing drug discovery is also expected to contribute the region's market growth. For instance, according to the data published by the Pharmaceutical Research and Manufacturers of America in 2024, it is stated that the U.S. biopharmaceutical industry exceeded $800 billion in direct output in 2022, and with the ripple effect of this production throughout the U.S. economy, supported an additional $850 billion in output through its suppliers and other sectors of the economy, for a total of more than $1.65 trillion. This combined, total output impact represents 3.6 percent of all U.S. output.

Asia Pacific is at the fastest growing pace in the global Microbiology Culture market share

Asia Pacific is currently experiencing the fastest growth in the global Microbiology Culture. The growing awareness of food safety and quality standards, coupled with stricter government regulations, has propelled the need for reliable microbiology culture methods to detect pathogens and ensure product safety. Additionally, the rise in healthcare infrastructure and research activities across Asia Pacific is contributing to the growing adoption of microbiology culture techniques for diagnostics, clinical applications, and scientific research.

Competitive Landscape

The major global players in the microbiology culture market include Merck KGaA, Eiken Chemical Co, Ltd., Hi-Media Laboratories, Neogen Corporation, BD, Thermo Fisher Scientific, Inc., Kerry Group, bioMerieux, Sartorius AG, and CONDALAB among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Microbiology Culture Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Culture Media Type
3.3. Snippet by Consistency
3.4. Snippet by Application
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising demand for biopharmaceuticals
- 4.1.2. Restraints
  - 4.1.2.1. High development costs
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Product

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product
- 6.1.2. Market Attractiveness Index, By Product
6.2. Culture Supplements*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Culture Instruments & Equipment
6.4. Culture Plastics
6.5. Others

7. By Culture Media Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Media Type
- 7.1.2. Market Attractiveness Index, By Culture Media Type
7.2. Simple Media*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Synthetic Media
7.4. Complex Media
7.5. Special Media

8. By Consistency

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
- 8.1.2. Market Attractiveness Index, By Consistency
8.2. Liquid Media*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Semi-solid Media
8.4. Solid Culture Media

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Food & Beverage Industry*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Water Testing
9.4. Pharmaceuticals
9.5. Cosmetics
9.6. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Media Type
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Media Type
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Media Type
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Media Type
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Media Type
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Merck KGaA*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Eiken Chemical Co, Ltd.
12.3. Hi-Media Laboratories
12.4. Neogen Corporation
12.5. BD
12.6. Thermo Fisher Scientific, Inc.
12.7. Kerry Group
12.8. bioMerieux
12.9. Sartorius AG
12.10. CONDALAB

LIST NOT EXHAUSTIVE